Atlas Trials

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

Clinical trial NCT05535166 · RECRUITING

Trial details

NCT number
NCT05535166
Sponsor
St. Jude Children's Research Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Medulloblastoma
Start date
2022-12-20
Primary completion
2035-07-01
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.